23.25
price down icon2.64%   -0.65
after-market アフターアワーズ: 23.25
loading

Pacira Biosciences Inc (PCRX) 最新ニュース

pulisher
Jun 18, 2025

Is the Options Market Predicting a Spike in Pacira BioSciences Stock? - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

Investors in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Should Contact the Shareholders Foundation in Connection with Lawsuit - Newswire :) Press Release Distribution

Jun 18, 2025
pulisher
Jun 18, 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025 - GlobeNewswire Inc.

Jun 18, 2025
pulisher
Jun 18, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Business Upturn

Jun 17, 2025
pulisher
Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

When the Price of (PCRX) Talks, People Listen - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 15, 2025

Rhumbline Advisers Sells 9,754 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

GAMMA Investing LLC Grows Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Have Pacira BioSciences Insiders Been Selling Stock? - simplywall.st

Jun 12, 2025
pulisher
Jun 11, 2025

Pacira (PCRX) Shares Promising Long-Term Data for Osteoarthritis Gene Therapy | PCRX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences (NASDAQ:PCRX) Seems To Use Debt Quite Sensibly - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 08, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

Pacira BioSciences (NASDAQ:PCRX) Raised to Buy at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,781 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Connect - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira (PCRX) BioSciences Grants Inducement Awards to New Employ - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira Expands Team: 19 New Hires Receive $1.8M in Stock Awards and Options - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Purchases 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Q3 EPS Estimate for Pacira BioSciences Raised by Analyst - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 01, 2025
pulisher
May 30, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 30, 2025
pulisher
May 30, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by ProShare Advisors LLC - Defense World

May 30, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Pacira BioSciences’s First Quarter 2025 Misses Estimates - Orthopedics This Week

May 29, 2025
pulisher
May 28, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Nuveen Asset Management LLC - Defense World

May 28, 2025
pulisher
May 26, 2025

Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire

May 26, 2025
pulisher
May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Reach Out - ACCESS Newswire

May 25, 2025
pulisher
May 24, 2025

Trading (PCRX) With Integrated Risk Controls - news.stocktradersdaily.com

May 24, 2025
pulisher
May 24, 2025

Ameriprise Financial Inc. Acquires 194,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 24, 2025
pulisher
May 24, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of “Hold” from Brokerages - Defense World

May 24, 2025
pulisher
May 22, 2025

Pacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57% - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Pacira at RBC Conference: Strategic Growth and Gene Therapy Focus - Investing.com

May 21, 2025
pulisher
May 18, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 18, 2025
pulisher
May 18, 2025

2025-05-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation | Press Release - Stockhouse

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Sells 458 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 18, 2025
pulisher
May 17, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Comerica Bank - Defense World

May 17, 2025
pulisher
May 17, 2025

Northern Trust Corp Buys 145,205 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 17, 2025
pulisher
May 15, 2025

PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy fo - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy for Knee Osteoarthritis | PCRX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Pacira BioSciences Presents New Data on the Effects of - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Revolutionary Gene Therapy PCRX-201 Overcomes Major Immune System Barrier in Knee Osteoarthritis Trial - Stock Titan

May 15, 2025
pulisher
May 14, 2025

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Pacira Biosciences announces $300M share repurchase program - MSN

May 14, 2025
pulisher
May 14, 2025

Non-Opioid Pain Leader Pacira BioSciences Sets Major Investor Presentations at RBC and Jefferies Conferences - Stock Titan

May 14, 2025
pulisher
May 14, 2025

(PCRX) Trading Report - news.stocktradersdaily.com

May 14, 2025
pulisher
May 13, 2025

Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation - PR Newswire

May 13, 2025
pulisher
May 13, 2025

2025-05-13 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRA) And Encourages Shareholders to Reach Out | Press Release - Stockhouse

May 13, 2025
pulisher
May 13, 2025

Raymond James Financial Inc. Invests $190,000 in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 13, 2025
pulisher
May 12, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Tower Research Capital LLC TRC - Defense World

May 12, 2025
$14.44
price up icon 1.09%
$9.18
price up icon 2.80%
$128.04
price up icon 1.87%
$290.91
price up icon 1.14%
drug_manufacturers_specialty_generic RDY
$14.94
price down icon 0.60%
$16.65
price down icon 0.63%
大文字化:     |  ボリューム (24 時間):